FARGO: FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Home » Clinical Trials » FARGO: FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Research area:

Rare disease

Disease:

Primary sclerosing cholangitis

Intervention:

Therapeutics – large molecules/biologics

Phase:

Phase IIa

Intervention

Therapeutics – large molecules/biologics

Funding awarded to

University of Birmingham

Public registration details (where available)

Planned trial start and expected end date

March 2024 to July 2026